Brief: Somalogic And Twist Bioscience Corporation Announce Partnership To Discover Novel Therapeutic Targets And Antibodies
18/08/2021 13:24
Aug 18 (Reuters) - Twist Bioscience Corp TWST.O :
* SOMALOGIC AND TWIST BIOSCIENCE CORPORATION ANNOUNCE
PARTNERSHIP
TO DISCOVER NOVEL THERAPEUTIC TARGETS AND ANTIBODIES
* TWIST BIOSCIENCE CORP - COLLABORATION AIMED AT CREATING
NOVEL
ANTIBODIES AND ENABLING INNOVATIVE DRUG DISCOVERY BASED ON KEY
DISEASE BIOMARKERS
* TWIST BIOSCIENCE - COLLABORATION TO ALLOW USE OF SOMASCAN
PLATFORM TO IDENTIFY ANTIBODIES AGAINST TARGETS RESULTING FROM
SOMALOGIC'S 7,000-PLEX ASSAY
Source text for Eikon: ID:nGNX8cRwtZ
Further company coverage: TWST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders